<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05036447</url>
  </required_header>
  <id_info>
    <org_study_id>STYRK DM1</org_study_id>
    <nct_id>NCT05036447</nct_id>
  </id_info>
  <brief_title>Myotonic Dystrophy Type 1 and Resistance Exercise</brief_title>
  <acronym>STYRK DM1</acronym>
  <official_title>Recovery After Moderate-Heavy Resistance Exercise in Myotonic Dystrophy Type 1-patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian School of Sport Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian School of Sport Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the response after one bout of moderate-heavy&#xD;
      resistance exercise in patients suffering from Myotonic Dystrophy type 1. There is still&#xD;
      doubt about if these patients could benefit from resistance exercise, or if this mode of&#xD;
      exercise is detrimental to their mobility and health. We aim to monitor the subjects during&#xD;
      the recovery phase and investigate recovery in several ways.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myotonic dystrophy type 1 (DM1) is an autosomal, dominantly inherited, muscular disease and&#xD;
      the most common muscular dystrophy amongst adults. The disease is characterized by&#xD;
      progressive myopathy and myotonia, first evident in the distal parts of the body: calves and&#xD;
      forearms, further progressing towards proximal parts. A recent review by Voet and co-workers&#xD;
      (2013) concludes that exercise is safe for DM1-patients, and based on our current knowledge,&#xD;
      DM1-patients should be able to gain positive adaptations from exercise. However, the&#xD;
      physiological outcomes of an exercise stimulus are not well studied in this population and&#xD;
      because of alterations in important Ca2+ handling systems the recovery processes might be&#xD;
      significantly different from healthy muscles.&#xD;
&#xD;
      The aim of this study is to investigate the acute responses to moderate-heavy resistance&#xD;
      exercise in DM1-patients. We aim to establish a timeline for recovery of muscle strength,&#xD;
      measured as maximal voluntary contraction. In line with this, we want to investigate if any&#xD;
      muscular damage has occurred with both direct and indirect measures, and possible mechanisms&#xD;
      leading to muscle damage, i.e. impaired Ca2+ handling.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 14, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Participants in both groups (patients and control) perform unilateral leg resistance exercise, contralateral leg serves as control</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in muscle strength</measure>
    <time_frame>Baseline, and 5 minutes, 3 hours, 24 hours, 48 hours, and 71 hours after exercise</time_frame>
    <description>Recovery of knee extension torque</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle protein synthesis rate</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Rate of muscle protein synthesis in m. vastus lateralis between baseline and 27 hours after final session of resistance exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle protein breakdown rate</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Rate of muscle protein breakdown in m. vastus lateralis between baseline and 27 hours after final session of resistance exercise</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in muscle damage</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Myofibrillar disruption and necrosis observed in muscle tissue samples from m. vastus lateralis with electron microscopy</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in muscle regeneration</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Appearance of macrophages, satellite cell localization, and disruption of membrane in single muscle fibers and cross-sections using confocal microscopy</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in calcium cycling</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Calcium cycling in muscle tissue samples from m. vastus lateralis</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in contractile function</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Assessment of contractile function in single muscle fibers from m. vastus lateralis</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in calcium-related protein abundances</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Levels of protein and phosphorylation status using Western blotting</description>
  </other_outcome>
  <other_outcome>
    <measure>Muscle fiber type</measure>
    <time_frame>Baseline</time_frame>
    <description>Fiber type composition in samples from m. vastus lateralis</description>
  </other_outcome>
  <other_outcome>
    <measure>Muscle fiber type</measure>
    <time_frame>27 hours after final session of resistance exercise</time_frame>
    <description>Fiber type composition in samples from m. vastus lateralis</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in heat shock proteins</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Localization and expression of heat shock proteins using Western blotting and Immunohistochemistry</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in anabolic signaling</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Expression and phosphorylation status of central mediators in anabolic signaling pathways using Western blotting</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in autophagy</measure>
    <time_frame>Baseline and 27 hours after final session of resistance exercise</time_frame>
    <description>Expression and phosphorylation status of central mediators in pathways regulating muscle protein breakdown using Western blotting</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in biomarkers of muscle damage</measure>
    <time_frame>Baseline, and 3 hours, 24 hours, 48 hours, 71 hours, and 96 hours after exercise</time_frame>
    <description>Levels of serum Creatine kinase, Myoglobin, and Troponin I</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in biomarker of muscle damage</measure>
    <time_frame>Baseline, and 20 hours, 44 hours, 68 hours, and 92 hours after exercise</time_frame>
    <description>Level of titin-N fragment in urine</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Fatigue</measure>
    <time_frame>Baseline, and 1 hour after exercise</time_frame>
    <description>Electrical stimulation of m. vastus lateralis and m. vastus medialis at 10, 20, 50, and 80 Hz</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in muscle stiffness</measure>
    <time_frame>Baseline, and 50 minutes after exercise</time_frame>
    <description>Muscle stiffness measured with shear wave elastography in static and dynamic conditions</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in muscle soreness</measure>
    <time_frame>Baseline, and 3 hours, 24 hours, 48 hours, and 71 hours after exercise</time_frame>
    <description>Subjective rating of muscle soreness using a visual analogue scale (0-10)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in muscle swelling</measure>
    <time_frame>Baseline, and 3 hours, 24 hours, 48 hours, and 71 hours after exercise</time_frame>
    <description>Thickness of m. vastus lateralis using ultrasound B-mode</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Myotonic Dystrophy 1</condition>
  <arm_group>
    <arm_group_label>DM1-Ex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Moderate-heavy resistance exercise of one leg in DM1-patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DM-Rest</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control leg (i.e. no exercise) in DM1-patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ctrl-Ex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Moderate-heavy resistance exercise of one leg in healthy participants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ctrl-Rest</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control leg (i.e. no exercise) in healthy participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate-Heavy Resistance Exercise</intervention_name>
    <description>Leg press: 3 x 8 repetitions at 75% of 1 repetition maximum, 3 minutes rest between sets.&#xD;
Knee extension: 3 x 6 repetitions at 85% of 1 repetition maximum, 3 minutes rest between sets.</description>
    <arm_group_label>Ctrl-Ex</arm_group_label>
    <arm_group_label>DM1-Ex</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed Myotonic Dystrophy type 1-diagnosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-ambulatory&#xD;
&#xD;
          -  Injuries to muscle-skeletal-system that prevents resistance exercise&#xD;
&#xD;
          -  Severe affection of the cardiovascular system&#xD;
&#xD;
          -  Cognitive affection&#xD;
&#xD;
          -  Lives more than one hour from test site&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Truls Raastad, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Norwegian School of Sport Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Truls Raastad, PhD</last_name>
    <phone>+47 23 26 23 28</phone>
    <email>truls.raastad@nih.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vilde Handegard, MSc</last_name>
    <phone>+47 23 26 23 47</phone>
    <email>vilde.handegard@nih.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Norwegian School of Sport Sciences</name>
      <address>
        <city>Oslo</city>
        <zip>0863</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Truls Raastad, PhD</last_name>
      <phone>+47 23 26 23 28</phone>
      <email>trulsr@nih.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 10, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Norwegian School of Sport Sciences</investigator_affiliation>
    <investigator_full_name>Truls Raastad</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Resistance exercise</keyword>
  <keyword>Recovery</keyword>
  <keyword>Muscle protein synthesis</keyword>
  <keyword>Muscle protein breakdown</keyword>
  <keyword>Muscle function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myotonic Dystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

